Comparing the current results to its competitors, Ss Innovations International Inc reported Revenue increase in the 2 quarter 2026 by 11.01 % year on year. The sales growth was above Ss Innovations International Inc's competitors' average revenue growth of 8.24 %, achieved in the same quarter.
Ss Innovations International Inc, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 14.97 %
Ss Innovations International Inc's Comment on Competition and Industry Peers
The company operates in a competitive environment that includes traditional open surgery, conventional minimally invasive surgery (MIS), drug therapies, radiation treatments, and emerging diagnostic and interventional surgical methods. Its success relies on clinical and technical innovation, product quality and reliability, and educating stakeholders about the advantages of robotic-assisted medical procedures using the SSi Mantra system. Competitors consist of both U.S. and international firms that develop, manufacture, and market robotic-assisted medical products. Notable competitors include Intuitive Surgical, Inc.; Asensus Surgical, Inc.; avateramedical GmbH; CMR Surgical Ltd.; Johnson & Johnson; Medicaroid Corporation; Medrobotics Corporation; Medtronic plc; meerecompany Inc.; Olympus Corporation; Samsung Electronics Co., Ltd.; Shandong Weigao Group Medical Polymer Company Ltd.; Shanghai Microport Medbot (Group) Co., Ltd.; and Titan Medical Inc. Many of these competitors have longer operating histories and greater financial resources. Additionally, companies with expertise in industrial robotics may enter the medical robotics sector, increasing competition. Inability to compete effectively could negatively impact the company's operations and future prospects.
Company's competitiveness improved within Overall company, with revenue growth of 11.01 % and its market share increased to approx. 0.13 %. << More on AVMR Market Share.
*Market share is calculated based on total revenue.
Publicly Traded Peers of Ss Innovations International Inc
Stryker Corp Share Performance
+5.90%
This Quarter
Stryker Corp
Profile
Stryker Corps business model focuses on innovation in medical technologies and devices, specializing in areas such as orthopedics, surgical equipment, and neurotechnology, to enhance patient care and improve outcomes in the healthcare industry.
Myomo Inc's business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.
Sources:
Ss Innovations International Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ss Innovations International Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
